Dimension Vista C1 In and 1 more
Complement C1 Inhibitor (Inactivator), Antigen, Antiserum, Control. 510(k) K072965, from Dade Behring, Inc. (Newark, DE). Product code DBA, class 2.
As of Nov 19, 2026, K072965 is an FDA 510(k) held by Dade Behring, Inc., substantially equivalent on Dec 21, 2007 after 60 days, with no recalls tied to it in FDA's recall database.
- Review time: 60 days
- Recalls: 0
Dimension Vista® C1IN Flex® reagent cartridge: The C1IN method is an in vitro diagnostic test for the quantitative measurement of C1 inhibitor in human serum and plasma on the Dimension Vista® System. Measurements of C1 Inhibitor aid in the diagnosis of hereditary angioneurotic edema (increase blood vessel permeability causing swelling of tissues) and a rare form of angioedema associated with…
- N Antiserum To C1 InhibitorK960257 · Behring Diagnostics, Inc. · Aug 1, 1996
- N Protein Standard PYK962410 · Behring Diagnostics, Inc. · Jul 16, 1996
- N/T Protein Control PYK962407 · Behring Diagnostics, Inc. · Jul 29, 1996
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Oct 22, 2007
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5250
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files